NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want ...
Natan, President and CEO of Harmonic Inc . (NASDAQ:HLIT), acquired a substantial number of shares in the company. The purchases consisted of 7,780 shares of common stock, with a total value of $75,060 ...
Humans are forward-looking. That can lead to preparation but also anxiety. On Thursday, optimism and relief won over fears ...
2h
Hosted on MSNIamgold (IAG) Stock Dips While Market Gains: Key FactsIn the latest market close, Iamgold (IAG) reached $6.54, with a -1.06% movement compared to the previous day. This change lagged the S&P 500's 1.04% gain on the day. Elsewhere, the Dow gained 0.77%, ...
Company executives on Thursday gave an explanation about how it views the 34 acres it acquired in 2017 for an estimated $336 ...
2h
Hosted on MSNXPeng Inc. Sponsored ADR (XPEV) Stock Drops Despite Market Gains: Important Facts to NoteIn the latest trading session, XPeng Inc. Sponsored ADR (XPEV) closed at $15.95, marking a -0.5% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 1.04% for ...
2h
Hosted on MSNACM Research, Inc. (ACMR) Laps the Stock Market: Here's WhyThe latest trading session saw ACM Research, Inc. (ACMR) ending at $23.20, denoting a +1.27% adjustment from its last day's close. This change outpaced the S&P 500's 1.04% gain on the day. At the same ...
VistaGen Therapeutics Inc . (NASDAQ:VTGN) reported a net loss of $14.1 million for the third quarter of fiscal year 2025, compared to a net loss of $6.4 million in the same period last year. The ...
On a per share basis, Kelly reported a loss of $0.90 in the fourth quarter of 2024, compared to earnings per share of $0.31 ...
The S&P 500 ended higher on Thursday, lifted by gains in Nvidia, Apple and Tesla, after U.S. President Donald Trump unveiled ...
Healthcare in vitro diagnostics company QuidelOrtho (NASDAQ: QDEL) attracted the right kind of attention from investors after ...
In a recent 8-K filing with the Securities and Exchange Commission, Eterna Therapeutics Inc. announced that its board of directors has scheduled the company's 2025 annual meeting of stockholders for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results